Literature DB >> 19198195

Resting and exercise response to altitude in patients with chronic obstructive pulmonary disease.

Paul T Kelly1, Maureen P Swanney, Josh D Stanton, Chris Frampton, Matthew J Peters, Lutz E Beckert.   

Abstract

INTRODUCTION: Exposure to altitude invariably involves some form of physical activity. There are limited data available to help predict the response to activity at altitude in patients with chronic obstructive pulmonary disease (COPD). The aim of the present study was to investigate the response to acute altitude exposure at rest and during exercise in patients with COPD.
METHODS: Sea level measures of cardio-pulmonary function were compared to the resting and exercise hypoxemic response at the summit of the Mt. Hutt ski field (2086 m), New Zealand, in 18 patients with COPD.
RESULTS: Ascent from sea level to altitude caused significant hypoxemia at rest (PaO2: 75 +/- 9 vs. 51 +/- 6 mmHg), and during a walk test (41 +/- 7 mmHg). At altitude, the walk test distance was reduced by 52%. Sea level PaO2 and SaO2 correlated with resting PaO2 (r = 0.69) and SaO2 (r = 0.79) at altitude. Diffusion capacity corrected for alveolar volume (K(CO)) correlated with resting SaO2 (r = 0.74) and exercise PaO2 (r = 0.75) at altitude. Aerobic capacity correlated with the walk test distance at altitude (r = 0.70). Spirometry, lung volumes, and ventilatory reserve did not correlate with the hypoxemic response to altitude. DISCUSSION: Baseline arterial oxygen levels and K(CO) are key measures in predicting the hypoxemic response to acute altitude exposure in patients with COPD. The impairment in gas exchange associated with COPD is a significant mechanism causing altitude-related hypoxemia in this group.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19198195     DOI: 10.3357/asem.2434.2009

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  4 in total

Review 1.  Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment.

Authors:  Kirsten Holthof; Pierre-Olivier Bridevaux; Isabelle Frésard
Journal:  BMC Pulm Med       Date:  2022-05-09       Impact factor: 3.320

2.  Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial.

Authors:  Lu Tan; Tsogyal D Latshang; Sayaka S Aeschbacher; Fabienne Huber; Deborah Flueck; Mona Lichtblau; Stefanie Ulrich; Elisabeth D Hasler; Philipp M Scheiwiller; Silvia Ulrich; Konrad E Bloch; Michael Furian
Journal:  JAMA Netw Open       Date:  2020-06-01

3.  Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trial.

Authors:  Michael Furian; Deborah Flueck; Tsogyal D Latshang; Philipp M Scheiwiller; Sebastian Daniel Segitz; Séverine Mueller-Mottet; Christian Murer; Adrian Steiner; Silvia Ulrich; Thomas Rothe; Malcolm Kohler; Konrad E Bloch
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-26

4.  Exercise Capacity, Ventilatory Response, and Gas Exchange in COPD Patients With Mild to Severe Obstruction Residing at High Altitude.

Authors:  Mauricio Gonzalez-Garcia; Margarita Barrero; Dario Maldonado
Journal:  Front Physiol       Date:  2021-06-18       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.